Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
13F holders, Q2 2024
Institutional positions in Evotec SE as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +8 vs. Q1 2024
- Shares held
- 7.29M
- +2.35M (+47.5%) vs. Q1 2024
- Total value
- $35.0M
- −$3.72M (−9.6%) vs. Q1 2024
- New holders
- 10
- 11 more added
- Sold out
- 2
- 2 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $9.07M |
| Q1 2026 | 46 | $20.3M |
| Q4 2025 | 44 | $30.4M |
| Q3 2025 | 37 | $35.9M |
| Q2 2025 | 37 | $40.5M |
| Q1 2025 | 25 | $30.4M |
| Q4 2024 | 26 | $36.9M |
| Q3 2024 | 24 | $29.6M |
| Q2 2024 | 28 | $35.0M |
| Q1 2024 | 20 | $38.7M |
| Q4 2023 | 28 | $66.5M |
| Q3 2023 | 24 | $12.0M |
| Q2 2023 | 20 | $15.4M |
| Q1 2023 | 19 | $14.5M |
| Q4 2022 | 22 | $21.1M |
| Q3 2022 | 22 | $43.5M |
| Q2 2022 | 21 | $57.3M |
| Q1 2022 | 22 | $83.3M |
| Q4 2021 | 20 | $157.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Evotec SE; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 149 | $0 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 59 | $283 | 0.00% | −658−91.8% | Reduced |
| Bell Investment Advisors, Inc | 69 | $332 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 109 | $523 | 0.00% | +109 | New |
| EverSource Wealth Advisors, LLC | 111 | $528 | 0.00% | +111 | New |
| Clearstead Advisors, LLC | 200 | $960 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 332 | $1.59K | 0.00% | +332 | New |
| Accent Capital Management, LLC | 412 | $1.98K | 0.00% | +412 | New |
| HHM Wealth Advisors, LLC | 450 | $2.16K | 0.00% | +450 | New |
| UBS Group AG | 1,030 | $4.94K | 0.00% | −736−41.7% | Reduced |
| Parallel Advisors, LLC | 1,540 | $7.39K | 0.00% | +1,470+2,100.0% | Added |
| US Bancorp | 1,698 | $8.15K | 0.00% | +1,122+194.8% | Added |
| Briaud Financial Planning, Inc | 2,160 | $10.0K | 0.01% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 2,088 | $10.0K | 0.00% | +1,784+586.8% | Added |
| Signaturefd, LLC | 4,484 | $21.5K | 0.00% | +3,436+327.9% | Added |
| Bank of America Corp | 5,968 | $28.6K | 0.00% | +1,887+46.2% | Added |
| ADAR1 Capital Management, LLC | 9,400 | $45.1K | 0.01% | +1,700+22.1% | Added |
| Citadel Advisors LLC | 11,444 | $54.9K | 0.00% | +11,444 | New |
| Mariner, LLC | 12,311 | $58.4K | 0.00% | +12,311 | New |
| Quadrant Capital Group LLC | 14,216 | $68.2K | 0.01% | +7,910+125.4% | Added |
| JustInvest LLC | 19,233 | $87.1K | 0.00% | +19,233 | New |
| Goldman Sachs Group Inc | 64,856 | $311.3K | 0.00% | +64,856 | New |
| BlackRock Inc. | 82,598 | $396.5K | 0.00% | +44,998+119.7% | Added |
| DCF Advisers, LLC | 114,953 | $551.8K | 0.29% | +67,156+140.5% | Added |
| Morgan Stanley | 121,810 | $584.7K | 0.00% | +34,204+39.0% | Added |
| Millennium Management LLC | 191,528 | $919.3K | 0.00% | +108,713+131.3% | Added |
| Wellington Management Group LLP | 2,031,576 | $9.75M | 0.00% | +2,031,576 | New |
| Mubadala Investment Co PJSC | 4,597,701 | $22.1M | 0.09% | 00.0% | Unchanged |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −41,507−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −24,543−100.0% | Sold out |